<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>20</Volume>
				<Issue>9</Issue>
				<PubDate PubStatus="epublish">
					<Year>2019</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>PIK3CA and PTEN Genes Expressions in Breast Cancer</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2841</FirstPage>
			<LastPage>2846</LastPage>
			<ELocationID EIdType="pii">88745</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2019.20.9.2841</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Nabil Hadi </FirstName>
					<LastName>Alowiri</LastName>
<Affiliation>Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt.</Affiliation>

</Author>
<Author>
					<FirstName>Shaden Muawia </FirstName>
					<LastName>Hanafy</LastName>
<Affiliation>Department of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt.</Affiliation>

</Author>
<Author>
					<FirstName>Reham Abdel </FirstName>
					<LastName>Haleem</LastName>
<Affiliation>Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation>

</Author>
<Author>
					<FirstName>Ahmed </FirstName>
					<LastName>Abdellatif</LastName>
<Affiliation>Surgical Oncology Unit, Department of General Surgery, Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>07</Month>
					<Day>22</Day>
				</PubDate>
			</History>
		<Abstract>Background: The phosphatidylinositol-3 kinase (PI3K) intracellular signaling pathway plays an important&lt;br /&gt;role in breast cancer. The current study aimed to evaluate the expressions of two main regulators of PI3K pathway;&lt;br /&gt;phosphatidylinositol-3- kinase catalytic subunit alpha as activator (PIK3CA), and phosphatase and tensin-homolog&lt;br /&gt;as inhibitor (PTEN), in breast carcinoma tissue, and compare with their expressions in adjacent normal breast tissue.&lt;br /&gt;Methods: A total of fifty female patients with breast carcinoma from surgical oncology unit of Alexandria-Main&lt;br /&gt;University Hospital were included in this study. The Quantitative Real Time PCR was used to quantify expressions of&lt;br /&gt;PIK3CA and PTEN. Results: PIK3CA mRNA expression was significantly increased in breast cancer tissues compared&lt;br /&gt;to normal breast tissues (P&lt;0.001, Z=5.700), also PTEN mRNA expression was significantly higher in breast carcinoma&lt;br /&gt;tissue compared to normal breast tissue (P&lt;0.001, Z=5.362). Conclusion: Increased the expressions of PIK3CA and&lt;br /&gt;PTEN mRNA in breast cancer tissue compared to normal breast tissue.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">PIK3CA</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PTEN</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Expressions</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_88745_424f3bb723f6b177971f007707b3b285.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
